NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has reached a settlement and licensing agreement with GeneSeek, resolving a patent dispute between the firms.
Genetic Technologies is granting GeneSeek non-exclusive rights to a number of its patents pertaining to non-coding DNA technology. Other terms were not disclosed.
GeneSeek, a Neogen company that provides agrigenomic and veterinary products and services, was one of 10 firms sued by Genetic Technologies in May 2011 for alleged infringement of US Patent No. 5,612,179, titled "Intron Sequence Analysis Method for Detection of Adjacent Locus Alleles as Haplotypes."
Along with Neogen/GeneSeek, the firms named in the lawsuit were Agilent Technologies; Bristol-Myers Squibb; Eurofins STA Laboratories; GlaxoSmithKline; Hologic; Merial; Navigenics; Pfizer; and 454 Life Sciences.
GeneSeek is the fourth firm to settle with Genetic Technologies, the Australian genetic test development firm said. It previously reached deals with Navigenics, Hologic, and Eurofins. Discussions with other companies named in the lawsuit are ongoing and progressing, Genetic Technologies added.